Dean J Mitchell - Net Worth and Insider Trading

Over the past 18 months, Dean J Mitchell made 1 insider transaction in Praxis Precision Medicines Inc (PRAX) with a net purchase of 50,000. Other recent insider transactions involving Praxis Precision Medicines Inc (PRAX) include a net purchase of 80,002 shares made by Marcio Souza , a net purchase of 14,500 shares made by Jill Desimone , and a net purchase of 8,000 shares made by Timothy Edwin Kelly .

In summary, during the past 3 months, insiders sold 0 shares of Praxis Precision Medicines Inc (PRAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Praxis Precision Medicines Inc (PRAX) were sold and 10,167 shares were bought by its insiders, resulting in a net purchase of 10,167 shares.

Praxis Precision Medicines Inc (PRAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Dean J Mitchell made no insider transaction in Immunogen Inc (IMGN). Other recent insider transactions involving Immunogen Inc (IMGN) include a net sale of 1,058,614 shares made by Theresa Wingrove , a net sale of 301,809 shares made by Stacy Ann Coen , and a net sale of 377,001 shares made by Renee Lentini .

In summary, during the past 3 months, insiders sold 0 shares of Immunogen Inc (IMGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,785,085 shares of Immunogen Inc (IMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,785,085 shares.

Immunogen Inc (IMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Dean J Mitchell made 1 insider transaction in Precigen Inc (PGEN) with a net purchase of 25,000. Other recent insider transactions involving Precigen Inc (PGEN) include a net sale of 204,273 shares made by Helen Sabzevari , a net sale of 12,301 shares made by Rutul R Shah , and a net sale of 6,806 shares made by Jeffrey Thomas Perez .

In summary, during the past 3 months, insiders sold 0 shares of Precigen Inc (PGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 455,706 shares of Precigen Inc (PGEN) were sold and 13,109,743 shares were bought by its insiders, resulting in a net purchase of 12,654,037 shares.

Precigen Inc (PGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Dean J Mitchell made no insider transaction in Theravance Biopharma Inc (TBPH). Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include a net sale of 25,787 shares made by Richard A Graham , a net sale of 10,229 shares made by Rhonda Farnum , and a net purchase of 1,499,124 shares made by Eli Samaha .

In summary, during the past 3 months, insiders sold 1,254 shares of Theravance Biopharma Inc (TBPH) in total and bought 1,499,124 shares, with a net purchase of 1,497,870 shares. During the past 18 months, 151,016 shares of Theravance Biopharma Inc (TBPH) were sold and 1,499,124 shares were bought by its insiders, resulting in a net purchase of 1,348,108 shares.

Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Dean J Mitchell made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net sale of 45,419 shares made by Ann Powell Judge , a net purchase of 5,071 shares made by Christopher S. Boerner , and a net sale of 240,000 shares made by Giovanni Caforio .

In summary, during the past 3 months, insiders sold 0 shares of Bristol-Myers Squibb Co (BMY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 336,536 shares of Bristol-Myers Squibb Co (BMY) were sold and 13,571 shares were bought by its insiders, resulting in a net sale of 322,965 shares.

Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Dean J Mitchell made no insider transaction in Kinnate Biopharma Inc (KNTE). Other recent insider transactions involving Kinnate Biopharma Inc (KNTE) include a net purchase of 2,866,100 shares made by Carl L Gordon , a net purchase of 2,866,100 shares made by Orbimed Advisors Llc , and a net purchase of 1,780,000 shares made by Foresite Capital Fund Iv, L.p. .

In summary, during the past 3 months, insiders sold 0 shares of Kinnate Biopharma Inc (KNTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kinnate Biopharma Inc (KNTE) were sold and 9,292,200 shares were bought by its insiders, resulting in a net purchase of 9,292,200 shares.

Kinnate Biopharma Inc (KNTE)'s detailed insider trading history can be found in Insider Trading Tracker table.